YiXi Biotech Closes Angel Round for Microbial Treatments

21:24 EDT 28 Oct 2019 | ChinaBio Today

Yixi Biotech of Nanjing has completed an angel round of several million dollars to support its portfolio of treatments for intestinal microbial diseases, starting with reconstructing bacteria after chemotherapy. The company will use the financing's proceeds for R&D of alternative treatment protocols, synthetic biological strains and drugs that treat intestinal microbial diseases. Founded earlier this year, Yixi Biotech aims to manage intestinal microorganisms so that people can have healthy intestinal microbial communities and avoid metabolic diseases. More details....

Original Article: YiXi Biotech Closes Angel Round for Microbial Treatments


More From BioPortfolio on "YiXi Biotech Closes Angel Round for Microbial Treatments"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...